CareDx Inc CDNA
News
CareDx Announces Third KOAR Analysis Published in Transplantation
CareDx Announces Third Quarter 2026 Financial Results
CareDx Announces New KOAR Data Linking Elevated AlloSure® Kidney to Nearly 3-Fold Higher Risk of Adverse Graft Outcomes in Patients with Borderline Rejection or TCMR at ASN Kidney Week 2026
CareDx to Report Third Quarter 2026 Financial Results on October 29, 2026